Please enable JavaScript to continue using this application.

Compare $CRVS vs $ODTX | Chartloom

Compare

$CRVS vs $ODTX

Corvus Pharmaceuticals Inc · Odyssey Therapeutics Inc

CRVS

Corvus Pharmaceuticals Inc

ODTX

Odyssey Therapeutics Inc

Compare $CRVS vs $ODTX

Comparing Corvus Pharmaceuticals Inc and Odyssey Therapeutics Inc

CRVSCorvus Pharmaceuticals Inc

ODTXOdyssey Therapeutics Inc

CRVSCorvus Pharmaceuticals Inc

Market cap

$885M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

43.7%

52W performance

50.3%

FCF yield

-5.1%

ODTXOdyssey Therapeutics Inc

Market cap

$913M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.0%

YTD performance

15.7%

52W performance

15.7%

FCF yield

-4.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRVS

ODTX

Detailed metrics comparison

CRVS

Corvus Pharmaceuticals Inc

ODTX

Odyssey Therapeutics Inc

Market Cap

CRVS$885M

ODTX$913M

Enterprise Value

CRVS$866M

ODTX$831M

Price

CRVS$10.52

ODTX$19.00

P/E Ratio

CRVSN/A

ODTXN/A

P/S Ratio

CRVS0.00x

ODTX306.64x

EV/Sales

CRVS0.00x

ODTX279.08x

EV/EBITDA

CRVS0.00x

ODTX0.00x

P/B Ratio

CRVS4.07x

ODTX2.36x

P/FCF Ratio

CRVSN/A

ODTXN/A

EV/FCF

CRVS-19.14x

ODTX-21.89x

PEG Ratio

CRVSN/A

ODTXN/A

Forward P/E (NTM)

CRVSN/A

ODTXN/A

Forward P/S (NTM)

CRVSN/A

ODTXN/A

Revenue (TTM)

CRVS$0

ODTX$3M

Revenue Growth (YoY)

CRVSN/A

ODTX-19.0%

Forward Rev Growth

CRVS1220.6%

ODTX410.3%

Gross Margin (TTM)

CRVS0.0%

ODTX0.0%

Operating Margin (TTM)

CRVS0.0%

ODTX0.0%

EBITDA Margin (TTM)

CRVS0.0%

ODTX-3193.4%

Net Margin (TTM)

CRVS0.0%

ODTX-8054.3%

FCF Margin (TTM)

CRVSN/A

ODTX-1275.0%

Net Income (TTM)

CRVS$-54M

ODTX$-240M

FCF (TTM)

CRVS$-45M

ODTX$-38M

EPS (TTM)

CRVS-$0.59

ODTX-$7.92

ROE (TTM)

CRVS-3615.0%

ODTX-3030.0%

ROA (TTM)

CRVS-3362.0%

ODTX-2554.0%

ROIC (TTM)

CRVS-3615.0%

ODTX-3030.0%

Cash

CRVS$19M

ODTX$82M

Debt

CRVS$0

ODTX$0

Net Cash/Debt

CRVS$19M

ODTX$82M

Current Ratio (TTM)

CRVS16.16x

ODTX11.36x

Quick Ratio (TTM)

CRVS15.92x

ODTX10.98x

Debt/Equity (TTM)

CRVS0.00x

ODTX0.00x

Debt/Assets (TTM)

CRVS0.0%

ODTX0.0%

Interest Coverage (TTM)

CRVSN/A

ODTXN/A

Net Debt/EBITDA (TTM)

CRVS0.00x

ODTX0.00x

Beta

CRVS1.59

ODTX-0.23

52W Performance

CRVS50.3%

ODTX15.7%

YTD Performance

CRVS43.7%

ODTX15.7%

% from 52W High

CRVS-61.0%

ODTX-34.6%

% from 52W Low

CRVS64.6%

ODTX25.8%

Asset Turnover (TTM)

CRVS0.00x

ODTX0.00x

FCF Yield (TTM)

CRVS-5.1%

ODTX-4.2%

Earnings Yield (TTM)

CRVS-6.1%

ODTX-26.3%

Dividend Yield (TTM)

CRVSN/A

ODTXN/A

Rule of 40

CRVS0.0

ODTX-1,294.1

EV/GP/RG

CRVSN/A

ODTXN/A

Ticker research

View CRVS research View ODTX research

Metric	CRVS Corvus Pharmaceuticals Inc	ODTX Odyssey Therapeutics Inc
Market & Valuation
Market Cap	$885M	$913M
Enterprise Value	$866M	$831M
Price	$10.52	$19.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	306.64x
EV/Sales	0.00x	279.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.07x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-19.14x	-21.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	-19.0%
Forward Rev Growth	1220.6%	410.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3193.4%
Net Margin (TTM)	0.0%	-8054.3%
FCF Margin (TTM)	N/A	-1275.0%
Net Income (TTM)	$-54M	$-240M
FCF (TTM)	$-45M	$-38M
EPS (TTM)	-$0.59	-$7.92
ROE (TTM)	-3615.0%	-3030.0%
ROA (TTM)	-3362.0%	-2554.0%
ROIC (TTM)	-3615.0%	-3030.0%
Financial Health
Cash	$19M	$82M
Debt	$0	$0
Net Cash/Debt	$19M	$82M
Current Ratio (TTM)	16.16x	11.36x
Quick Ratio (TTM)	15.92x	10.98x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.59	-0.23
52W Performance	50.3%	15.7%
YTD Performance	43.7%	15.7%
% from 52W High	-61.0%	-34.6%
% from 52W Low	64.6%	25.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.1%	-4.2%
Earnings Yield (TTM)	-6.1%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,294.1
EV/GP/RG	N/A	N/A
Ticker research	View CRVS research	View ODTX research

Valuation

P/S Ratio

CRVS

0.00x

ODTX

306.64x

EV/FCF

ODTX

-21.89x

CRVS

-19.14x

Growth & revenue

Revenue Growth TTM

ODTX

-19.0%

Forward Revenue Growth

CRVS

1220.6%

ODTX

410.3%

Profitability & performance

Gross Margin

CRVS

0.0%

ODTX

0.0%

ROE

ODTX

-3030.0%

CRVS

-3615.0%

FCF Yield %

ODTX

-4.2%

CRVS

-5.1%

52-Week Performance

CRVS

50.3%

ODTX

15.7%

Detailed metrics comparison

CRVS

Corvus Pharmaceuticals Inc

ODTX

Odyssey Therapeutics Inc

Market Cap

CRVS$885M

ODTX$913M

Enterprise Value

CRVS$866M

ODTX$831M

Price

CRVS$10.52

ODTX$19.00

P/E Ratio

CRVSN/A

ODTXN/A

P/S Ratio

CRVS0.00x

ODTX306.64x

EV/Sales

CRVS0.00x

ODTX279.08x

EV/EBITDA

CRVS0.00x

ODTX0.00x

P/B Ratio

CRVS4.07x

ODTX2.36x

P/FCF Ratio

CRVSN/A

ODTXN/A

EV/FCF

CRVS-19.14x

ODTX-21.89x

PEG Ratio

CRVSN/A

ODTXN/A

Forward P/E (NTM)

CRVSN/A

ODTXN/A

Forward P/S (NTM)

CRVSN/A

ODTXN/A

Revenue (TTM)

CRVS$0

ODTX$3M

Revenue Growth (YoY)

CRVSN/A

ODTX-19.0%

Forward Rev Growth

CRVS1220.6%

ODTX410.3%

Gross Margin (TTM)

CRVS0.0%

ODTX0.0%

Operating Margin (TTM)

CRVS0.0%

ODTX0.0%

EBITDA Margin (TTM)

CRVS0.0%

ODTX-3193.4%

Net Margin (TTM)

CRVS0.0%

ODTX-8054.3%

FCF Margin (TTM)

CRVSN/A

ODTX-1275.0%

Net Income (TTM)

CRVS$-54M

ODTX$-240M

FCF (TTM)

CRVS$-45M

ODTX$-38M

EPS (TTM)

CRVS-$0.59

ODTX-$7.92

ROE (TTM)

CRVS-3615.0%

ODTX-3030.0%

ROA (TTM)

CRVS-3362.0%

ODTX-2554.0%

ROIC (TTM)

CRVS-3615.0%

ODTX-3030.0%

Cash

CRVS$19M

ODTX$82M

Debt

CRVS$0

ODTX$0

Net Cash/Debt

CRVS$19M

ODTX$82M

Current Ratio (TTM)

CRVS16.16x

ODTX11.36x

Quick Ratio (TTM)

CRVS15.92x

ODTX10.98x

Debt/Equity (TTM)

CRVS0.00x

ODTX0.00x

Debt/Assets (TTM)

CRVS0.0%

ODTX0.0%

Interest Coverage (TTM)

CRVSN/A

ODTXN/A

Net Debt/EBITDA (TTM)

CRVS0.00x

ODTX0.00x

Beta

CRVS1.59

ODTX-0.23

52W Performance

CRVS50.3%

ODTX15.7%

YTD Performance

CRVS43.7%

ODTX15.7%

% from 52W High

CRVS-61.0%

ODTX-34.6%

% from 52W Low

CRVS64.6%

ODTX25.8%

Asset Turnover (TTM)

CRVS0.00x

ODTX0.00x

FCF Yield (TTM)

CRVS-5.1%

ODTX-4.2%

Earnings Yield (TTM)

CRVS-6.1%

ODTX-26.3%

Dividend Yield (TTM)

CRVSN/A

ODTXN/A

Rule of 40

CRVS0.0

ODTX-1,294.1

EV/GP/RG

CRVSN/A

ODTXN/A

Ticker research

View CRVS research View ODTX research

Metric	CRVS Corvus Pharmaceuticals Inc	ODTX Odyssey Therapeutics Inc
Market & Valuation
Market Cap	$885M	$913M
Enterprise Value	$866M	$831M
Price	$10.52	$19.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	306.64x
EV/Sales	0.00x	279.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.07x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-19.14x	-21.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	-19.0%
Forward Rev Growth	1220.6%	410.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3193.4%
Net Margin (TTM)	0.0%	-8054.3%
FCF Margin (TTM)	N/A	-1275.0%
Net Income (TTM)	$-54M	$-240M
FCF (TTM)	$-45M	$-38M
EPS (TTM)	-$0.59	-$7.92
ROE (TTM)	-3615.0%	-3030.0%
ROA (TTM)	-3362.0%	-2554.0%
ROIC (TTM)	-3615.0%	-3030.0%
Financial Health
Cash	$19M	$82M
Debt	$0	$0
Net Cash/Debt	$19M	$82M
Current Ratio (TTM)	16.16x	11.36x
Quick Ratio (TTM)	15.92x	10.98x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.59	-0.23
52W Performance	50.3%	15.7%
YTD Performance	43.7%	15.7%
% from 52W High	-61.0%	-34.6%
% from 52W Low	64.6%	25.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.1%	-4.2%
Earnings Yield (TTM)	-6.1%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,294.1
EV/GP/RG	N/A	N/A
Ticker research	View CRVS research	View ODTX research